Valuation : Brooks Laboratories Limited

Market Cap 1.94B 20.35M 17.47M 16.36M 14.98M 28.22M 28.29M 194M 75.72M 980M 76.42M 74.77M 3.24B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.96B 20.55M 17.64M 16.51M 15.12M 28.48M 28.56M 196M 76.43M 989M 77.14M 75.47M 3.27B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
44.12%
Yield 2025 *
-
Yield 2026 -
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-18 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-06 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-10-16 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
25-08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-28 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
25-02-13 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-12-26 Brooks Laboratories Limited Appoints Ms. Krutika Mohan Rane as Company Secretary & Compliance Officer, Effective 26 December 2024 CI
1 day+5.00%
1 week+11.70%
Current month+8.22%
1 month+3.19%
3 months+11.41%
6 months-2.96%
Current year-17.66%
1 week 59
Extreme 59
65.99
1 month 57.5
Extreme 57.5
65.99
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
163.9
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer 58 2002-01-22
Chief Executive Officer - 2026-05-31
President 57 2023-08-22
Director TitleAgeSince
Director/Board Member 53 2022-11-22
Director/Board Member 62 2010-09-09
Director/Board Member - 2023-08-22
Change 5-day change 1-year change 3-year change Capi.($)
+5.00%+11.70%-52.66%-29.87% 19.41M
+0.73%+0.70%+19.56%+71.29% 47.78B
-0.37%+1.04%+54.31%+121.86% 40.3B
+1.23%-0.14%-10.12%+15.55% 11.88B
+3.41%+7.67%+20.38%+87.48% 12.03B
+0.19%0.00%+30.98%+150.00% 9.24B
+0.45%+3.73%+25.09%+46.01% 7.83B
-1.41%-0.16%+52.26%-11.99% 7.34B
+0.89%+9.50%+26.11%+220.67% 7.21B
+0.95%-8.22%-39.88%+16.67% 5.28B
Average +1.11%+1.85%+12.61%+68.77% 14.89B
Weighted average by Cap. +0.55%+1.06%+27.48%+86.57%

Financials

2025 2026
Net sales 826M 8.64M 7.42M 6.95M 6.36M 11.98M 12.02M 82.26M 32.16M 416M 32.45M 31.75M 1.38B 857M 8.98M 7.71M 7.21M 6.61M 12.44M 12.48M 85.43M 33.4M 432M 33.7M 32.98M 1.43B
Net income -99.67M -1.04M -896K -839K -768K -1.45M -1.45M -9.93M -3.88M -50.23M -3.92M -3.83M -166M 246M 2.57M 2.21M 2.07M 1.89M 3.57M 3.58M 24.5M 9.58M 124M 9.66M 9.46M 410M
Net Debt 75.39M 789K 678K 634K 581K 1.09M 1.1M 7.51M 2.94M 38M 2.96M 2.9M 126M 18.44M 193K 166K 155K 142K 268K 268K 1.84M 718K 9.29M 725K 709K 30.75M
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
26-08-27 ₹65.99 +5.00% 63,076
26-08-26 ₹62.85 +1.65% 7,763
26-08-25 ₹61.83 +0.24% 11,626
26-08-24 ₹61.68 +2.80% 7,625
26-08-21 ₹60.00 -0.50% 18,992
  1. Stock Market
  2. Stocks
  3. BROOKS Stock